{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:05:06Z","timestamp":1794243906201,"version":"4.9.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"UMN Department of Surgery Research Support"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-11271-9","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T09:58:06Z","timestamp":1752832686000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Inhibition of fatty acid binding protein suppresses pancreatic cancer progression and metastasis"],"prefix":"10.1038","volume":"15","author":[{"given":"Shuhei","family":"Shinoda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuho","family":"Inoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuho","family":"Sato-Dahlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Carmella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Hecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Bernlohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayeed","family":"Ikramuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"key":"11271_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.pan.2014.10.001","volume":"15","author":"M Hidalgo","year":"2015","unstructured":"Hidalgo, M. et al. Addressing the challenges of pancreatic cancer: future directions for improving outcomes. Pancreatology 15, 8\u201318 (2015).","journal-title":"Pancreatology"},{"key":"11271_CR2","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib, L. et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the united States. Cancer Res. 74, 2913\u20132921 (2014).","journal-title":"Cancer Res."},{"key":"11271_CR3","doi-asserted-by":"crossref","unstructured":"Park, W., Chawla, A. & O\u2019Reilly, E. M. Pancreatic cancer: A review.  JAMA 326, 851\u2013862 (2021).","DOI":"10.1001\/jama.2021.13027"},{"key":"11271_CR4","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.cgh.2020.02.054","volume":"19","author":"N Khalaf","year":"2021","unstructured":"Khalaf, N. et al. Burden of pancreatic cancer: from epidemiology to practice. Clin. Gastroenterol. Hepatol. 19, 876\u2013884 (2021).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"11271_CR5","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"11271_CR6","unstructured":"Wood, L. D. et al. Pancreatic Cancer: Pathogenesis, Screening, Diagnosis, and Treatment (Gastroenterology, 2022)."},{"key":"11271_CR7","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1093\/ije\/dyac025","volume":"51","author":"Y Lu","year":"2022","unstructured":"Lu, Y. et al. Assessment of causal effects of visceral adipose tissue on risk of cancers: a Mendelian randomization study. Int. J. Epidemiol. 51, 1204\u20131218 (2022).","journal-title":"Int. J. Epidemiol."},{"key":"11271_CR8","doi-asserted-by":"publisher","first-page":"253","DOI":"10.7150\/ijbs.27420","volume":"15","author":"J Jiang","year":"2019","unstructured":"Jiang, J. et al. Adiponectin suppresses human pancreatic Cancer growth through attenuating the beta-Catenin signaling pathway. Int. J. Biol. Sci. 15, 253\u2013264 (2019).","journal-title":"Int. J. Biol. Sci."},{"key":"11271_CR9","doi-asserted-by":"publisher","first-page":"C375","DOI":"10.1152\/ajpcell.00379.2020","volume":"320","author":"T Kawai","year":"2021","unstructured":"Kawai, T., Autieri, M. V. & Scalia, R. Adipose tissue inflammation and metabolic dysfunction in obesity. Am. J. Physiol. Cell. Physiol. 320, C375\u2013C391 (2021).","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"11271_CR10","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.2337\/db16-1477","volume":"66","author":"DK Andersen","year":"2017","unstructured":"Andersen, D. K. et al. Diabetes, pancreatogenic diabetes, and pancreatic Cancer. Diabetes 66, 1103\u20131110 (2017).","journal-title":"Diabetes"},{"key":"11271_CR11","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.pan.2019.08.008","volume":"19","author":"B Zhou","year":"2019","unstructured":"Zhou, B. et al. Obesity and pancreatic cancer: an update of epidemiological evidence and molecular mechanisms. Pancreatology 19, 941\u2013950 (2019).","journal-title":"Pancreatology"},{"key":"11271_CR12","doi-asserted-by":"crossref","unstructured":"Shinoda, S. et al. Obesity and pancreatic cancer: Recent progress in epidemiology, mechanisms and bariatric surgery. Biomedicines 10, 1284  (2022).","DOI":"10.3390\/biomedicines10061284"},{"key":"11271_CR13","first-page":"23","volume":"8","author":"M Furuhashi","year":"2014","unstructured":"Furuhashi, M. et al. Fatty Acid-Binding protein 4 (FABP4): pathophysiological insights and potent clinical biomarker of metabolic and cardiovascular diseases. Clin. Med. Insights Cardiol. 8, 23\u201333 (2014).","journal-title":"Clin. Med. Insights Cardiol."},{"key":"11271_CR14","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nrendo.2015.122","volume":"11","author":"GS Hotamisligil","year":"2015","unstructured":"Hotamisligil, G. S. & Bernlohr, D. A. Metabolic functions of FABPs\u2013mechanisms and therapeutic implications. Nat. Rev. Endocrinol. 11, 592\u2013605 (2015).","journal-title":"Nat. Rev. Endocrinol."},{"key":"11271_CR15","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1016\/j.atherosclerosis.2007.04.045","volume":"195","author":"A Cabre","year":"2007","unstructured":"Cabre, A. et al. Fatty acid binding protein 4 is increased in metabolic syndrome and with Thiazolidinedione treatment in diabetic patients. Atherosclerosis 195, e150\u2013e158 (2007).","journal-title":"Atherosclerosis"},{"key":"11271_CR16","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.gene.2018.07.035","volume":"676","author":"M Amiri","year":"2018","unstructured":"Amiri, M. et al. Diverse roles of fatty acid binding proteins (FABPs) in development and pathogenesis of cancers. Gene 676, 171\u2013183 (2018).","journal-title":"Gene"},{"key":"11271_CR17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/pin.12756","volume":"69","author":"Y Cui","year":"2019","unstructured":"Cui, Y., Song, M. & Kim, S. Y. Prognostic significance of fatty acid binding protein-4 in the invasive ductal carcinoma of the breast. Pathol. Int. 69, 68\u201375 (2019).","journal-title":"Pathol. Int."},{"key":"11271_CR18","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1158\/0008-5472.CAN-19-1999","volume":"80","author":"A Mukherjee","year":"2020","unstructured":"Mukherjee, A. et al. Adipocyte-Induced FABP4 expression in ovarian Cancer cells promotes metastasis and mediates carboplatin resistance. Cancer Res. 80, 1748\u20131761 (2020).","journal-title":"Cancer Res."},{"key":"11271_CR19","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1186\/s12935-020-01582-4","volume":"20","author":"W Tian","year":"2020","unstructured":"Tian, W. et al. FABP4 promotes invasion and metastasis of colon cancer by regulating fatty acid transport. Cancer Cell. Int. 20, 512 (2020).","journal-title":"Cancer Cell. Int."},{"key":"11271_CR20","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/PAI.0000000000000306","volume":"25","author":"Y Luo","year":"2017","unstructured":"Luo, Y. et al. LDHB and FABP4 are associated with progression and poor prognosis of pancreatic ductal adenocarcinomas. Appl. Immunohistochem. Mol. Morphol. 25, 351\u2013357 (2017).","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"11271_CR21","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.soard.2021.12.002","volume":"18","author":"K Wirth","year":"2022","unstructured":"Wirth, K. et al. Fatty acid binding protein 4 regulates pancreatic cancer cell proliferation via activation of nuclear factor E2-related factor 2. Surg. Obes. Relat. Dis. 18, 485\u2013493 (2022).","journal-title":"Surg. Obes. Relat. Dis."},{"key":"11271_CR22","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/35077213","volume":"411","author":"GI Evan","year":"2001","unstructured":"Evan, G. I. & Vousden, K. H. Proliferation, cell cycle and apoptosis in cancer. Nature 411, 342\u2013348 (2001).","journal-title":"Nature"},{"key":"11271_CR23","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","volume":"29","author":"I Pastushenko","year":"2019","unstructured":"Pastushenko, I. & Blanpain, C. EMT transition States during tumor progression and metastasis. Trends Cell. Biol. 29, 212\u2013226 (2019).","journal-title":"Trends Cell. Biol."},{"key":"11271_CR24","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1158\/1078-0432.CCR-06-2926","volume":"13","author":"B Hotz","year":"2007","unstructured":"Hotz, B. et al. Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer. Clin. Cancer Res. 13, 4769\u20134776 (2007).","journal-title":"Clin. Cancer Res."},{"key":"11271_CR25","doi-asserted-by":"crossref","unstructured":"Rodriguez-Aznar, E. et al. EMT and stemness-Key players in pancreatic cancer stem cells. Cancers (Basel)  11 (2019).","DOI":"10.3390\/cancers11081136"},{"key":"11271_CR26","doi-asserted-by":"publisher","first-page":"6024","DOI":"10.1021\/jm900720m","volume":"52","author":"AV Hertzel","year":"2009","unstructured":"Hertzel, A. V. et al. Identification and characterization of a small molecule inhibitor of fatty acid binding proteins. J. Med. Chem. 52, 6024\u20136031 (2009).","journal-title":"J. Med. Chem."},{"key":"11271_CR27","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s11605-020-04681-9","volume":"25","author":"B Giri","year":"2021","unstructured":"Giri, B. et al. An immunocompetent model of pancreatic Cancer resection and recurrence. J. Gastrointest. Surg. 25, 1271\u20131279 (2021).","journal-title":"J. Gastrointest. Surg."},{"key":"11271_CR28","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/ncb3513","volume":"19","author":"AM Krebs","year":"2017","unstructured":"Krebs, A. M. et al. The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. Nat. Cell. Biol. 19, 518\u2013529 (2017).","journal-title":"Nat. Cell. Biol."},{"key":"11271_CR29","doi-asserted-by":"publisher","first-page":"E814","DOI":"10.1152\/ajpendo.00465.2005","volume":"290","author":"AV Hertzel","year":"2006","unstructured":"Hertzel, A. V. et al. Lipid metabolism and adipokine levels in fatty acid-binding protein null and Transgenic mice. Am. J. Physiol. Endocrinol. Metab. 290, E814\u2013E823 (2006).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"11271_CR30","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1053\/j.gastro.2019.12.010","volume":"158","author":"M Perusina Lanfranca","year":"2020","unstructured":"Perusina Lanfranca, M. et al. Interleukin 22 signaling regulates acinar cell plasticity to promote pancreatic tumor development in mice. Gastroenterology 158, 1417\u20131432 (2020). e11.","journal-title":"Gastroenterology"},{"key":"11271_CR31","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1002\/ijc.33172","volume":"147","author":"B Xia","year":"2020","unstructured":"Xia, B. et al. Metabolic syndrome and risk of pancreatic cancer: A population-based prospective cohort study. Int. J. Cancer. 147, 3384\u20133393 (2020).","journal-title":"Int. J. Cancer"},{"key":"11271_CR32","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/joim.13013","volume":"287","author":"SB Gribsholt","year":"2020","unstructured":"Gribsholt, S. B. et al. Hospital-diagnosed overweight and obesity related to cancer risk: a 40-year Danish cohort study. J. Intern. Med. 287, 435\u2013447 (2020).","journal-title":"J. Intern. Med."},{"key":"11271_CR33","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1053\/j.gastro.2021.03.021","volume":"161","author":"VK Rustgi","year":"2021","unstructured":"Rustgi, V. K. et al. Bariatric surgery reduces Cancer risk in adults with nonalcoholic fatty liver disease and severe obesity. Gastroenterology 161, 171\u2013184 (2021). e10.","journal-title":"Gastroenterology"},{"key":"11271_CR34","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.surg.2018.08.007","volume":"165","author":"C Jahansouz","year":"2019","unstructured":"Jahansouz, C. et al. Serum FABP4 concentrations decrease after Roux-en-Y gastric bypass but not after intensive medical management. Surgery 165, 571\u2013578 (2019).","journal-title":"Surgery"},{"key":"11271_CR35","doi-asserted-by":"publisher","first-page":"32679","DOI":"10.1074\/jbc.R110.135210","volume":"285","author":"J Storch","year":"2010","unstructured":"Storch, J. & Thumser, A. E. Tissue-specific functions in the fatty acid-binding protein family. J. Biol. Chem. 285, 32679\u201332683 (2010).","journal-title":"J. Biol. Chem."},{"key":"11271_CR36","doi-asserted-by":"publisher","first-page":"597","DOI":"10.2174\/1389450122666210712193654","volume":"23","author":"K Majchrzak","year":"2022","unstructured":"Majchrzak, K. et al. Adipocyte fatty acid binding protein (A-FABP) as a potential new therapeutic target for the treatment of Obesity - Associated cancers. Curr. Drug Targets. 23, 597\u2013605 (2022).","journal-title":"Curr. Drug Targets"},{"key":"11271_CR37","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1002\/ijc.28903","volume":"135","author":"H Uehara","year":"2014","unstructured":"Uehara, H. et al. Exogenous fatty acid binding protein 4 promotes human prostate cancer cell progression. Int. J. Cancer. 135, 2558\u20132568 (2014).","journal-title":"Int. J. Cancer"},{"key":"11271_CR38","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.mce.2017.02.002","volume":"462","author":"S Guaita-Esteruelas","year":"2018","unstructured":"Guaita-Esteruelas, S. et al. The peritumoural adipose tissue microenvironment and cancer. The roles of fatty acid binding protein 4 and fatty acid binding protein 5. Mol. Cell. Endocrinol. 462, 107\u2013118 (2018).","journal-title":"Mol. Cell. Endocrinol."},{"key":"11271_CR39","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/nm.2492","volume":"17","author":"KM Nieman","year":"2011","unstructured":"Nieman, K. M. et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat. Med. 17, 1498\u20131503 (2011).","journal-title":"Nat. Med."},{"key":"11271_CR40","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.devcel.2019.04.010","volume":"49","author":"W Lu","year":"2019","unstructured":"Lu, W. & Kang, Y. Epithelial-Mesenchymal plasticity in Cancer progression and metastasis. Dev. Cell. 49, 361\u2013374 (2019).","journal-title":"Dev. Cell."},{"key":"11271_CR41","doi-asserted-by":"crossref","unstructured":"Nieto, M. A. et al. Emt: 2016.  Cell 166, 21\u201345 (2016).","DOI":"10.1016\/j.cell.2016.06.028"},{"key":"11271_CR42","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nature16064","volume":"527","author":"X Zheng","year":"2015","unstructured":"Zheng, X. et al. Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature 527, 525\u2013530 (2015).","journal-title":"Nature"},{"key":"11271_CR43","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1038\/ncb1998","volume":"11","author":"U Wellner","year":"2009","unstructured":"Wellner, U. et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting MicroRNAs. Nat. Cell. Biol. 11, 1487\u20131495 (2009).","journal-title":"Nat. Cell. Biol."},{"key":"11271_CR44","doi-asserted-by":"publisher","first-page":"e16186","DOI":"10.1371\/journal.pone.0016186","volume":"6","author":"R Strauss","year":"2011","unstructured":"Strauss, R. et al. Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity. PLoS One. 6, e16186 (2011).","journal-title":"PLoS One"},{"key":"11271_CR45","doi-asserted-by":"publisher","first-page":"110676","DOI":"10.1016\/j.biopha.2020.110676","volume":"131","author":"D Xue","year":"2020","unstructured":"Xue, D., Zhou, X. & Qiu, J. Emerging role of NRF2 in ROS-mediated tumor chemoresistance. Biomed. Pharmacother. 131, 110676 (2020).","journal-title":"Biomed. Pharmacother"},{"key":"11271_CR46","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1158\/0008-5472.CAN-17-2465","volume":"78","author":"J Hao","year":"2018","unstructured":"Hao, J. et al. Expression of adipocyte\/macrophage fatty Acid-Binding protein in Tumor-Associated macrophages promotes breast Cancer progression. Cancer Res. 78, 2343\u20132355 (2018).","journal-title":"Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11271-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11271-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11271-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T15:39:15Z","timestamp":1757259555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11271-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11271"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-11271-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"17 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experimental procedures using animals were approved by the University of Minnesota Institutional Animal Care and Use Committee (IACUC, #1911\u201337568\u00a0A).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"26084"}}